Talk:Vayarin
 | This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Vayarin.
|
sources
[edit]searched for high quality sources...
- there are no reviews on Vayarin in pubmed from the last five years, per this.
- there are no reviews on Vayarin in pubmed at all, per this
- there are no reviews on Lipirinen in pubmed per this
- no mention of lipirinen on fda website per this
- one mention of Vayarin on fda website per this; that one hit is this GRAS notification from ECA Healthcare about phosphatidylserine from fish lecithin; (their tradename, "DHAPS").
- Searched FDA website for enzymotec and found four GRAS notifications from enzymotec:
- GRN 223: Phosphatidylserine; Intended use - Ingredient in milk, flavored milk, milk drinks (excluding milk, fluid), milk imitation (soy milk), milk-based meal replacement, yogurt, breakfast bars and fruit flavored drink at levels of 100 milligrams (mg) phosphatidylserine per serving and in breakfast cereals and milk (fluid) at 50 mg/serving. Enzymotec Ltd., Israel. Date of closure - December 20, 2007. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=223. Marketed per this as "Sharp-PS".
- GRN 279: Phosphatidylserine derived from fish; Intended use - Ingredient in breakfast cereals, dairy product analogs, grain products and pastas, milk products and processed fruits and fruit juices at levels intended to provide 30 mg of phosphatidylserine per serving; and as an ingredient of medical foods at levels that would not exceed 300 mg of phosphatidylserine per day. Enzymotec Ltd., Israel. Date of closure - July 29, 2009. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=279. (per this not branded when they submitted)
- GRN 311: Krill-based phosphatidylserine; Intended use - Ingredient in breakfast cereals, dairy product analogs, grain products and pastas, milk products and processed fruits and fruit juices at a use level intended to provide 30 mg of phosphatidylserine per serving; and as an ingredient in medical foods at levels that would not exceed 300 mg of phosphatidylserine per day. Enzymotec Ltd., Israel. Date of closure – June 15, 2010. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=311. per this not branded when they submitted
- GRN 545: Phosphatidylserine derived from sunflower; Intended use – same as GRN 223 except medical foods. Intended for use in milk, flavored milk, milk drinks (excluding milk, fluid), milk imitation (soy milk), milk-based meal replacement, yogurt, breakfast bars and fruit flavored drink at levels of 100 mg PS per serving; in breakfast cereals and milk (fluid) at 50 mg/serving; and in medical foods at levels not to exceed 300 mg/serving. Enzymotec Ltd., Israel. Date of closure – June 5, 2015. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=545.
just to be sure checked
So none.
Less good sources - science-oriented popular media
- Maucieri, Larry (May 19, 2015). "What Is "Medical Food" for ADHD?". "The Distracted Couple" Blog on Psychology Today.
- nothing in Scientific American.
- nothing on wired
- nothing at MIT Tech Review
- less good sources - mainstream media
- nothing in NY Times.
- nothing at LA Times
- nothing at WSJ
-- OK then. Jytdog (talk) 22:31, 19 September 2016 (UTC)